Cryselle Kit
Product Images NDC 71205-803

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cryselle (NDC 71205-803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norgestrel Strustural Formula (Image 1)

Chemical structure of the active ingredient shown in the image, depicting a steroid backbone with specific functional groups including a hydroxyl (OH) and an ethynyl group (C≡CH).*

FDA Label Image

Ethinyl Estradiol Structural Formula (Image 2)

Chemical structure of Ethinyl Estradiol, showing its characteristic steroid rings and functional groups including an ethynyl group and hydroxyl groups.*

FDA Label Image

1 (Image 3)

A forest plot chart comparing effect estimates from several studies on Ever COC versus Naver COC use and current COC use versus Naver use. The horizontal axis represents effect estimates ranging from -1.50 to 2.00, with studies listed on the left and corresponding confidence intervals on the right. Each study's point estimate is marked with a dot and horizontal lines indicating confidence intervals.*

FDA Label Image

Chart 1 (Image 4)

A vertical chart depicting pregnancy rates per 100 women in one year, ranked from fewer pregnancies at the top to more pregnancies at the bottom. It categorizes various birth control methods by effectiveness, listing implants, injections, intrauterine devices, and sterilization at the top with fewer than 1 pregnancy per 100 women; birth control pills, skin patch, and vaginal ring in the next group; condoms and diaphragm lower down; then no sex during fertile days, spermicide, and withdrawal; and at the bottom, no birth control with the highest pregnancy rate.*

FDA Label Image

1 (Image 5)

Cryselle kit containing 28 tablets arranged in a 4-week pill pack. The pack includes white tablets for the first three weeks and light-green colored tablets for the fourth week. Each tablet contains 0.3 mg Norgestrel and 0.03 mg Ethinyl Estradiol. The label indicates storage instructions and the NDC number 0555-9049-79.*

FDA Label Image

Pick Correct Day Label Blister Image (Image 6)

An instructional diagram showing how to apply the correct day label to a Cryselle oral contraceptive tablet card. It illustrates a hand peeling a day label strip (Thursday to Wednesday) to place on the top of the 28-day tablet card, which is labeled with Cryselle and displays 28 circular tablet positions in a 4-row layout.*

FDA Label Image

71205-803-28 (Image 7)

Label for Cryselle 0.3mg/0.03mg tablets by Proficient Rx LP, containing 28 tablets. Each tablet includes 0.3 mg norgestrel and 0.03 mg ethinyl estradiol. The label details 21 active white, round, film-coated, biconvex tablets and 7 inert light-green uncoated tablets. Manufactured by Teva Pharmaceuticals USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.